HER2-negative Breast Cancer Clinical Trials in Jacksonville, Florida
2 recruitingJacksonville, Florida
Showing 1–2 of 2 trials
Recruiting
Phase 1Phase 2
Trial of 225Ac-DOTATATE (RYZ101) in Subjects With ER+, HER2-negative Unresectable or Metastatic Breast Cancer Expressing SSTRs.
Metastatic Breast CancerHER2-negative Breast CancerAdvanced Breast Cancer+1 more
RayzeBio, Inc.124 enrolled31 locationsNCT06590857
Recruiting
DiviTum®TKa: A Biomarker Assay for Efficacy in HR+ Metastatic Breast Cancer Patients
HER2-negative Breast Cancer
Mayo Clinic100 enrolled1 locationNCT06388122